Otrdiena, 2026. gada 03. novembris 16:43
Vārda dienas: Dagnija, Ērika
JSC “Grindeks” is pleased to announce the successful passing of the U.S. Food and Drug Administration inspection. The issued certification paves the way for “Grindeks” cooperation with the U.S. partners, developing its business activities on the American market and allows “Grindeks” start exporting its manufactured Xylazine, Xylazine Hydrochloride and Droperidol to the U.S., as well as continue supplying Oxytocine and Detomidine to its American partners.
Lai lasītu visu rakstu, lūdzu, ienāciet sistēmā
Biržas NASDAQ OMX Rigas birojs: Vaļņu iela 1, Rīga, LV1050
E-pasta adrese: [email protected]
Lursoft laikrakstu bibliotēkā pieejami raksti no 01.06.2011 līdz 30.06.2014
(0)
